193 related articles for article (PubMed ID: 31964555)
1. Subcutaneous vaccination with a live attenuated Yersinia pseudotuberculosis plague vaccine.
Derbise A; Guillas C; Gerke C; Carniel E; Pizarro-Cerdà J; Demeure CE
Vaccine; 2020 Feb; 38(8):1888-1892. PubMed ID: 31964555
[TBL] [Abstract][Full Text] [Related]
2. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
[TBL] [Abstract][Full Text] [Related]
3. Oral vaccination against plague using Yersinia pseudotuberculosis.
Demeure CE; Derbise A; Carniel E
Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
[TBL] [Abstract][Full Text] [Related]
4. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.
Derbise A; Cerdà Marín A; Ave P; Blisnick T; Huerre M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2012; 6(2):e1528. PubMed ID: 22348169
[TBL] [Abstract][Full Text] [Related]
5. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J
Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064
[TBL] [Abstract][Full Text] [Related]
6. A Recombinant Attenuated
Singh AK; Curtiss R; Sun W
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331960
[TBL] [Abstract][Full Text] [Related]
7. Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.
Blisnick T; Ave P; Huerre M; Carniel E; Demeure CE
Infect Immun; 2008 Aug; 76(8):3808-16. PubMed ID: 18505804
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
Kilgore PB; Sha J; Hendrix EK; Motin VL; Chopra AK
mBio; 2021 Dec; 12(6):e0322321. PubMed ID: 34872353
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.
Tiner BL; Sha J; Ponnusamy D; Baze WB; Fitts EC; Popov VL; van Lier CJ; Erova TE; Chopra AK
Clin Vaccine Immunol; 2015 Dec; 22(12):1255-68. PubMed ID: 26446423
[TBL] [Abstract][Full Text] [Related]
10. Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques.
Zhang Q; Wang Q; Tian G; Qi Z; Zhang X; Wu X; Qiu Y; Bi Y; Yang X; Xin Y; He J; Zhou J; Zeng L; Yang R; Wang X
Hum Vaccin Immunother; 2014; 10(2):368-77. PubMed ID: 24225642
[TBL] [Abstract][Full Text] [Related]
11. Protection Induced by Oral Vaccination with a Recombinant
Majumder S; Olson RM; Singh A; Wang X; Li P; Kittana H; Anderson PE; Anderson DM; Sun W
Infect Immun; 2022 Aug; 90(8):e0016522. PubMed ID: 35900096
[TBL] [Abstract][Full Text] [Related]
12. Immunity in plague: protection of the vervet (Cercopithecus aethips) against pneumonic plague by the oral administration of live attenuated Yersinia pestis.
Chen TH; Elberg SS; Eisler DM
J Infect Dis; 1977 Feb; 135(2):289-93. PubMed ID: 402428
[TBL] [Abstract][Full Text] [Related]
13. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.
Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W
FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
Philipovskiy AV; Smiley ST
Infect Immun; 2007 Feb; 75(2):878-85. PubMed ID: 17118978
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague.
Sun W; Sanapala S; Rahav H; Curtiss R
Vaccine; 2015 Nov; 33(48):6727-35. PubMed ID: 26514425
[TBL] [Abstract][Full Text] [Related]
16. Dual route vaccination for plague with emergency use applications.
Moore BD; New RRC; Butcher W; Mahood R; Steward J; Bayliss M; MacLeod C; Bogus M; Williamson ED
Vaccine; 2018 Aug; 36(34):5210-5217. PubMed ID: 30017148
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague.
Davies ML; Biryukov SS; Rill NO; Klimko CP; Hunter M; Dankmeyer JL; Miller JA; Shoe JL; Mlynek KD; Talyansky Y; Toothman RG; Qiu J; Bozue JA; Cote CK
Front Immunol; 2024; 15():1397579. PubMed ID: 38835755
[TBL] [Abstract][Full Text] [Related]
18. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
[TBL] [Abstract][Full Text] [Related]
19. LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.
Sun W; Sanapala S; Henderson JC; Sam S; Olinzock J; Trent MS; Curtiss R
Infect Immun; 2014 Oct; 82(10):4390-404. PubMed ID: 25114109
[TBL] [Abstract][Full Text] [Related]
20. Immunity in plague: protection induced in Cercopithecus aethiops by oral administration of live, attenuated Yersinia pestis.
Chen TH; Elbert SS; Eisler DM
J Infect Dis; 1976 Mar; 133(3):302-9. PubMed ID: 815445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
